Compass Pathways Plc (CMPS) Stock Analysis

Compass Pathways Plc (CMPS) is a publicly traded company in the HEALTHCARE sector. It trades at $13.33, carries a market capitalization of $1.91B. This page summarizes the public market data, fundamentals, and frequently asked questions for CMPS, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - MEDICAL CARE FACILITIES

Exchange: NASDAQ

Key Metrics

• Price: $13.33
• Market Cap: $1.91B
• EPS: $-3.14
• 52-Week High: $14.76
• 52-Week Low: $2.25

Market Sentiment

Compass Pathways Plc currently has a Bullish sentiment score of 0.28.

About Compass Pathways Plc

Compass Pathways plc is a leading mental health care company dedicated to innovating treatments for mental health conditions through the development of psychedelic therapies, particularly psilocybin. Based in Cheshire, UK, and active in both the UK and US markets, the company is at the forefront of clinical research aimed at addressing significant unmet needs in mental health care, notably for treatment-resistant depression. With a robust commitment to research and development, Compass Pathwa...

GNG Research Analysis

GNG Research scores Compass Pathways Plc (CMPS) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for CMPS.

Frequently Asked Questions

Does CMPS pay dividends?

Compass Pathways Plc (CMPS) does not currently pay a regular dividend.

What is CMPS's market cap?

Compass Pathways Plc (CMPS) has a market capitalization of $1.91B with a current stock price of $13.33.